Skip to main content

Table 2 Clinical and pathological features of the patients who experienced recurrence

From: Assessment of the prognostic role of neutrophil-to-lymphocyte ratio following complete resection of thymoma

Pt # Age Sex MG NLR NT WHO Masaoka TNM AT DFS Site OS LFU
14 36 M yes 2.16 no B3 III IIIA yes 27 LR 31 AL
15 63 M no 5.85 no B3 III IIIB yes 16 LR 47 AL
32 50 M no 1.68 yes B2 IV IIIA yes 48 LR 61 AL
39 36 M no 2.27 no B2 III I yes 48 LR 99 AL
50 72 M no 2.46 no B3 II I yes 24 LR 75 D
66 52 F no 2.61 yes B2 III IIIA yes 57 LR 59 AL
  1. Legend: NT Neoadjuvant therapy, AT Adjuvant therapy, LR Loco-regional recurrence, LFU Status at the time of the last follow up, AL Alive, D Deceased